Neurocrine wants to develop new obesity drugs. It's reportedly nearing an acquisition to accelerate that move.
神经分泌生物科学神经分泌生物科学(US:NBIX) MarketWatch·2026-04-06 19:04

Soleno Therapeutics股价飙升 - Soleno Therapeutics股票在周一盘前交易中大幅上涨 [1] - 股价上涨的直接原因是市场报告称Neurocrine Biosciences接近达成收购该公司的交易 [1] 潜在的并购交易 - 生物制药公司Neurocrine Biosciences可能正在推进对Soleno Therapeutics的收购 [1] - 市场对这笔潜在交易反应积极 推动了Soleno Therapeutics股价在盘前交易时段走高 [1]

Neurocrine wants to develop new obesity drugs. It's reportedly nearing an acquisition to accelerate that move. - Reportify